03/14/2026
Two non-intoxicating compounds from cannabis just showed surprising potential against one of the
world's fastest-growing diseases.
Researchers found that CBD and CBG may help combat fatty liver disease by boosting the liver's energy
reserves and restoring its cellular cleanup systems.
Fatty liver disease affects roughly 1 in 4 adults globally. It occurs when fat accumulates in liver cells,
leading to inflammation, scarring, and eventually liver failure. There is currently no approved drug
treatment.
In the study, both CBD and CBG improved the liver's ability to process fat and activated autophagy — the
cell's natural recycling system that clears damaged components.
Importantly, neither compound caused the psychoactive "high" associated with THC. These are the same
compounds already used in many wellness products.
This is still early-stage research and not a recommendation to self-treat. But the results are promising
enough that clinical trials may follow.
The liver might have an unexpected ally.
Source: ScienceDaily, March 2026
Shared for informational purposes only. This is not medical advice. Consult a healthcare professional
